title: Comparative efficacy and the window of radioprotection for adrenergic and serotoninergic agents and aminothiols in experiments with small and large animals.
abstract: This review gives a comparative evaluation of the radioprotective properties and the therapeutic index (TI) of radioprotectors from various pharmacological group in experiments on both small and large animals. It presents a hypothesis explaining the decrease in the TI of cystamine and 5-methoxytryptamine (mexamine), and the retention of that of α1-adrenomimetic indralin, and also compares the effects on large and small animals. The considerable differences in the therapeutic indices of catecholamines, serotonin and cystamine are a consequence of specific features of their mechanisms of radioprotective action. Radioprotectors acting via receptor mediation tend to provide a more expanded window of protection. The reduction in the TI of cystamine in larger animals, such as dogs, may be caused by the greater increase in toxicity of aminothiols in relation to the decrease in their optimal doses for radioprotective effect in going from mice to dogs, which is a consequence of the slower metabolic processes in larger animals. The somatogenic phase of intoxication by cystamine is significantly longer than the duration of its radioprotective effect, and increases with irradiation. The decrease in the radioprotective effect and the TI of mexamine in experiments with dogs may be caused by their lower sensitivity to the acute hypoxia induced by the mexamine. This is because of lower gradient in oxygen tension between tissue cells and blood capillaries under acute hypoxia that is determined by lower initial oxygen consumption in a large animal as compared with a small animal. Indralin likely provides optimal radioprotective effects and a higher TI for large animals via the increased specificity of its adrenergic effect on tissue respiration, which supports the development of acute hypoxia in the radiosensitive tissues of large animals. The stimulatory effect of indralin on early post-irradiation haematopoietic recovery cannot provide a high level of radioprotective action for large animals, but it may promote recovery.
authors.affiliation: State Scientific Center Russian Federation - Institute of Biomedical Problems, Russian Academy of Science, 76a Khoroshovskoe schuss, Moscow123007, Russia mikhail-v-vasin@yandex.ru.
authors.forename: Mikhail V
authors.initials: MV
authors.lastname: Vasin
authors.affiliation: State Scientific Center Russian Federation - Institute of Biomedical Problems, Russian Academy of Science, 76a Khoroshovskoe schuss, Moscow123007, Russia.
authors.forename: Igor B
authors.initials: IB
authors.lastname: Ushakov
mesh_terms: D008735:5-Methoxytryptamine / Q000008:administration & dosage*; D018663:Adrenergic Agents / Q000008:administration & dosage*; D004999:Amifostine / Q000008:administration & dosage*; D000818:Animals; D006224:Cricetinae; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D019317:Evidence-Based Medicine; D000882:Haplorhini; D051379:Mice; D011832:Radiation Injuries / Q000517:prevention & control*; D011836:Radiation Tolerance / Q000187:drug effects; D011837:Radiation-Protective Agents / Q000008:administration & dosage*; D051381:Rats; D018490:Serotonin Agents / Q000008:administration & dosage*; D013045:Species Specificity; D016896:Treatment Outcome
chemical_list: D018663:Adrenergic Agents; D011837:Radiation-Protective Agents; D018490:Serotonin Agents; D008735:5-Methoxytryptamine; D004999:Amifostine
keywords: 5-methoxytryptamine; cystamine; epinephrine; indralin; norepinephrine; serotonin; therapeutic index